glp-1 and ssri Getting to Know Peptides GLP-1 Medications – Community Education

Rare but serious gastrointestinal complications have been reported in post-marketing surveillance, including: Acute pancreatitis : If suspected, the GLP-1 agonist should be stopped immediately and not restarted if pancreatitis is confirmed Severe gastroparesis : Rare post-marketing reports of severe delayed gastric emptying Intestinal obstruction : Very rare cases reported in post-marketing surveillance Patients should be advised to seek urgent medical help via NHS 111, A&E or 999 as appropriate if they experience severe or persistent abdominal pain, persistent vomiting, abdominal distension, inability to pass stool or gas, or bloody diarrhoea whilst taking GLP-1 agonists

This could be due to a combination of physiological changes in taste perception and psychological factors related to weight loss and dietary shifts

Dietary nutrient deficiencies and risk of depression (review article 2018-2023)

MORE: Most costly add-on procedures marketed to improve IVF success show little benefit, study says Among the sites that required provider interaction, 13 used video calls and three used phone calls

rather, it is a customized therapy intended to address specific taurine deficiencies or therapeutic goals in patients

Persistent Fatigue : Ongoing tiredness or muscle weakness that doesnt improve with rest